SPATA31F3

gene
On this page

Summary

SPATA31F3 (SPATA31 subfamily F member 3, HGNC:42673) is a protein-coding gene on chromosome 9p13.3, encoding Protein SPATA31F3 (A6NFA0).

Predicted to be located in membrane.

Source: NCBI Gene 100129969 — RefSeq curated summary.

At a glance

  • MANE Select transcript: NM_001309427

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:42673
Approved symbolSPATA31F3
NameSPATA31 subfamily F member 3
Location9p13.3
Locus typegene with protein product
StatusApproved
Ensembl geneENSG00000187791
Ensembl biotypeprotein_coding
Entrez100129969

Gene structure

Transcript identifiers

Ensembl transcripts: 3 — 3 protein_coding

ENST00000340783, ENST00000603592, ENST00000603640

RefSeq mRNA: 3 — MANE Select: NM_001309427 NM_001309426, NM_001309427, NM_001375894

CCDS: CCDS83358, CCDS83359

Canonical transcript exons

ENST00000340783 — 5 exons

ExonStartEnd
ENSE000013826143488906634889632
ENSE000013833333489304634893152
ENSE000034770113489503934895084
ENSE000035826013489557934895764
ENSE000036644673489444134894501

Expression profiles

Bgee: expression breadth broad, 64 present calls, max score 92.23.

FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0131 / max 11.0594, expressed in 3 samples.

FANTOM5 promoters (1 alternative TSS)

Promoter IDTPM avgSamples expressed
1005500.01313

Top tissues by expression

210 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
spermCL:000001992.23gold quality
right testisUBERON:000453488.65gold quality
left testisUBERON:000453386.96gold quality
testisUBERON:000047384.22gold quality
tibialis anteriorUBERON:000138580.14silver quality
ileal mucosaUBERON:000033175.59silver quality
cardiac muscle of right atriumUBERON:000337969.84gold quality
left ventricle myocardiumUBERON:000656668.99gold quality
kidney epitheliumUBERON:000481965.61gold quality
deltoidUBERON:000147665.58gold quality
myocardiumUBERON:000234965.56gold quality
epithelial cell of pancreasCL:000008365.41gold quality
adult organismUBERON:000702363.13gold quality
pancreatic ductal cellCL:000207960.33silver quality
quadriceps femorisUBERON:000137756.50gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099155.55gold quality
endothelial cellCL:000011553.77gold quality
upper arm skinUBERON:000426353.52gold quality
nasal cavity epitheliumUBERON:000538453.24gold quality
vastus lateralisUBERON:000137953.18gold quality
oocyteCL:000002352.89gold quality
mucosa of sigmoid colonUBERON:000499351.49gold quality
cerebellar vermisUBERON:000472051.06gold quality
tendon of biceps brachiiUBERON:000818850.19silver quality
colonic epitheliumUBERON:000039749.42silver quality
colonic mucosaUBERON:000031748.10gold quality
skeletal muscle tissueUBERON:000113447.50gold quality
layer of synovial tissueUBERON:000761645.45gold quality
amniotic fluidUBERON:000017345.40gold quality
buccal mucosa cellCL:000233645.23gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no1.99

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

29 targeting SPATA31F3, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-453199.9969.703181
HSA-MIR-548M99.7068.871749
HSA-MIR-5004-5P99.6866.631294
HSA-MIR-509399.6769.262291
HSA-MIR-5197-5P99.6469.081494
HSA-MIR-466399.6265.33957
HSA-MIR-1213199.4868.721673
HSA-MIR-1224-5P99.4865.59803
HSA-MIR-57899.4668.361787
HSA-MIR-56999.4266.321009
HSA-MIR-3678-3P99.3167.101432
HSA-MIR-397399.2069.191990
HSA-MIR-807799.1766.67862
HSA-MIR-607199.1667.771780
HSA-MIR-7160-5P99.1167.172207
HSA-MIR-873-5P98.8466.901348
HSA-MIR-7851-3P98.7264.88980
HSA-MIR-2467-3P98.6567.181969
HSA-MIR-6842-3P98.0766.331325
HSA-MIR-891A-3P98.0567.99970
HSA-MIR-6765-3P97.8364.591165
HSA-MIR-365297.7165.431890
HSA-MIR-443097.4765.611813
HSA-MIR-3173-5P97.3565.821282
HSA-MIR-6799-3P97.3565.601302
HSA-MIR-3622A-3P97.0666.431000
HSA-MIR-3622B-3P96.8266.36988
HSA-MIR-4740-5P96.2567.96726
HSA-MIR-503-3P92.8966.09537

Cross-species orthologs

1 orthologs

OrganismSymbolGene ID
rattus_norvegicusSpata31f3ENSRNOG00000022751

Paralogs (13): SPATA31C2 (ENSG00000177910), SPATA31E1 (ENSG00000177992), SPATA31A6 (ENSG00000185775), SPATA31D3 (ENSG00000186788), SPATA31D4 (ENSG00000189357), SPATA31A1 (ENSG00000204849), SPATA31F1 (ENSG00000205108), SPATA31D1 (ENSG00000214929), SPATA31C1 (ENSG00000230246), (ENSG00000251545), SPATA31A3 (ENSG00000275969), SPATA31A7 (ENSG00000276040), SPATA31A5 (ENSG00000276581)

Protein

Protein identifiers

Protein SPATA31F3A6NFA0 (reviewed: A6NFA0)

Alternative names: Protein FAM205C

All UniProt accessions (3): A0A0U1RRG8, A0A0U1RRK5, A6NFA0

UniProt curated annotations — full annotation on UniProt →

Subcellular location. Membrane.

Similarity. Belongs to the SPATA31 family.

RefSeq proteins (3): NP_001296355, NP_001296356, NP_001362823 (=MANE)

Domains & families (InterPro)

IDNameType
IPR027970SPATA31-likeDomain

Pfam: PF15371

UniProt features (5 total): chain 1, transmembrane region 1, region of interest 1, compositionally biased region 1, modified residue 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-A6NFA0-F149.900.01

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Post-translational modifications (1): 152

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 15 (showing top): chr9p13, ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY, GSE14386_UNTREATED_VS_IFNA_TREATED_ACT_PBMC_MS_PATIENT_UP, GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_12H_UP, MIR7160_5P, MIR12131, MIR6842_3P, MIR1224_5P, GSE19772_CTRL_VS_HCMV_INF_MONOCYTES_DN, GSE21033_3H_VS_12H_POLYIC_STIM_DC_DN, GSE21033_3H_VS_24H_POLYIC_STIM_DC_UP, GSE21033_1H_VS_12H_POLYIC_STIM_DC_UP, GSE37532_TREG_VS_TCONV_CD4_TCELL_FROM_VISCERAL_ADIPOSE_TISSUE_UP, GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_TCONV_CD4_TCELL_DN, GSE37532_WT_VS_PPARG_KO_LN_TREG_DN

GO Biological Process (0):

GO Molecular Function (0):

GO Cellular Component (1): membrane (GO:0016020)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cellular anatomical structure1

Protein interactions and networks

STRING

2 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
SPATA31F3CITO145780

IntAct

0 interactions, top by confidence:

ESM2 similar proteins: A0A096MK47, A0JNH1, A6H5Y1, A6NCI8, A6NFA0, A6NGG8, B2RQL2, D3Z1D3, D3ZMK9, E9Q286, E9Q309, M0RD54, O14513, P51816, Q01613, Q03172, Q05860, Q2M2Z5, Q32LN6, Q3MHH3, Q3UXL4, Q3V0A6, Q569L8, Q571I4, Q5DTX6, Q5FW52, Q5HYW2, Q5R9I1, Q5VT06, Q5VWP3, Q60988, Q66HG9, Q68DA7, Q6P1W5, Q6P9P0, Q6PAC4, Q6PG16, Q711Q0, Q7TP36, Q7TSA6

Diamond homologs: A6NFA0, C0HKD1, C0HKD2, C0HKD3, Q32LN6, Q642A3, Q6ZU69, Q80YD3, Q63HN1, Q6ZQQ2, P0C874, Q6ZUB0

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

0 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance0
Likely benign0
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

797 predictions. Top by Δscore:

VariantEffectΔscore
9:34893149:CTGG:Cacceptor_gain1.0000
9:34894437:TTAC:Tdonor_loss1.0000
9:34894439:A:AGdonor_loss1.0000
9:34894498:CTAG:Cacceptor_gain1.0000
9:34894500:AG:Aacceptor_gain1.0000
9:34894502:C:CCacceptor_gain1.0000
9:34889633:CTT:Cacceptor_gain0.9900
9:34889636:C:CCacceptor_gain0.9900
9:34893150:TGG:Tacceptor_gain0.9900
9:34893153:C:CCacceptor_gain0.9900
9:34893154:T:Cacceptor_loss0.9900
9:34894435:GATTA:Gdonor_gain0.9900
9:34894437:TTA:Tdonor_gain0.9900
9:34894438:TA:Tdonor_gain0.9900
9:34894496:TCCTA:Tacceptor_gain0.9900
9:34894499:TAG:Tacceptor_gain0.9900
9:34893151:GG:Gacceptor_gain0.9800
9:34894436:ATTAC:Adonor_gain0.9800
9:34894439:A:ACdonor_gain0.9800
9:34894439:A:Tdonor_gain0.9800
9:34894440:C:CCdonor_gain0.9800
9:34889634:TT:Tacceptor_gain0.9700
9:34893040:TCTCA:Tdonor_loss0.9600
9:34893041:CTCAC:Cdonor_loss0.9600
9:34893042:TCA:Tdonor_loss0.9600
9:34893043:CACCT:Cdonor_loss0.9600
9:34893044:A:Gdonor_loss0.9600
9:34894493:TTCTC:Tacceptor_gain0.9600
9:34894511:C:CTacceptor_gain0.9600
9:34889632:GCTTC:Gacceptor_gain0.9500

AlphaMissense

1362 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
9:34893109:A:GC99R0.876
9:34895649:G:TA25E0.869
9:34893108:C:GC99S0.861
9:34893109:A:TC99S0.861
9:34893107:A:CC99W0.860
9:34893083:G:CC107W0.858
9:34895659:A:GC22R0.857
9:34893084:C:TC107Y0.850
9:34893085:A:GC107R0.833
9:34893145:A:GW87R0.833
9:34893145:A:TW87R0.833
9:34895667:C:TG19E0.832
9:34893094:A:GC104R0.817
9:34893108:C:TC99Y0.817
9:34894447:A:GM82T0.804
9:34893084:C:AC107F0.801
9:34893092:G:CC104W0.801
9:34893120:C:GR95P0.797
9:34893111:A:TL98Q0.792
9:34895705:A:CF6L0.792
9:34895705:A:TF6L0.792
9:34895707:A:GF6L0.792
9:34895668:C:GG19R0.781
9:34895668:C:TG19R0.781
9:34893143:C:AW87C0.778
9:34893143:C:GW87C0.778
9:34893084:C:GC107S0.773
9:34893085:A:TC107S0.773
9:34895652:A:TI24N0.759
9:34894459:A:GL78P0.748

dbSNP variants (sampled 300 via entrez): RS1000029920 (9:34895036 T>C,G), RS1000079999 (9:34889249 A>G), RS1001089294 (9:34893981 G>A), RS1001737675 (9:34893450 A>C), RS1001884607 (9:34893654 G>A), RS1002071305 (9:34891565 G>A), RS1003269010 (9:34896835 T>TA), RS1003791271 (9:34890062 G>C), RS1005297368 (9:34894883 C>A,T), RS1005512161 (9:34891749 C>A,T), RS1005638495 (9:34893829 G>C,T), RS1005648631 (9:34894119 A>G,T), RS1005972273 (9:34892206 C>A,G,T), RS1006940542 (9:34897644 A>G), RS1007525129 (9:34890555 C>T)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.